SAN CLEMENTE, Calif. (AP) _ Glaukos Corp. (GKOS) on Wednesday reported a loss of $13.5 million in its third quarter.
On a per-share basis, the San Clemente, California-based company said it had a loss of 37 cents. Losses, adjusted for non-recurring costs, were 10 cents per share.
The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share.
The glaucoma treatments developer posted revenue of $58.5 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $56.5 million.
Glaukos expects full-year revenue in the range of $229 million to $232 million.
Glaukos shares have risen 11% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $62.36, a climb of 6% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GKOS at https://www.zacks.com/ap/GKOS
Automated Insights, source Associated Press News